Thu May 17 20:52:22 SGT 2012  
SHIM CLINIC
MEN'S CLINIC SINGAPORE™
168 Bedok South Avenue 3 #01-473
Singapore 460168
Tel: (+65) 6100 7446
Fax: (+65) 6449 7446
24hr Answering Tel: (+65) 6333 5550
Web: www.ShimClinic.com
Opening Hours
Monday to Friday: 9 am to 3 pm, 7 pm to 11 pm
Saturday & Sunday: 7 pm to 11 pm
Public Holidays: Closed
Last registration: half hour before closing time.
Walk-in clinic. Appointments not required.
Bring NRIC, Work Pass or Passport for registration.
If for STD testing, hold urine 4 hours before arriving.

Finasteride | Shim Clinic, MEN'S CLINIC SINGAPORE™

Share |
Summary

Finasteride | Shim Clinic, MEN'S CLINIC SINGAPORE™: Androgenic alopecia, male pattern baldness, male pattern hair loss, treatment is available with finasteride (Propecia®) clinic, Singapore. Private and confidential service. Definitions, references, and latest news.

Description

Androgenic alopecia / male pattern baldness / male pattern hair loss treatment is available with a 5-alpha-reductase inhibitor like Finasteride (Propecia®)

Men's health issues:

References
Latest News

FDA revises finasteride labels
Thu, 03 May 2012 04:00:00 +0100 | Drug Topics - Pharmacy News
The labels of 2 formulations of finasteride, used to treat enlarged prostates and male-patterned baldness, are being revised to indicate that additional sexual side effects may persist after the drug has been discontinued, FDA announced. (Source: Drug Topics - Pharmacy News)

FDA Warns on Propecia Sexual Dysfunction: Threat Remains
Tue, 01 May 2012 19:10:12 +0100 | PRWeb: Medical Pharmaceuticals
On April 11th, 2012, the U.S. FDA announced changes to the labels for Propecia (finasteride) and Proscar to expand the list of sexual adverse events reported to FDA as some of these events have been...(PRWeb May 01, 2012)Read the full story at http://www.prweb.com/releases/2012/5/prweb9458683.htm (Source: PRWeb: Medical Pharmaceuticals)

[Prevention of uro-oncological diseases.]
Thu, 26 Apr 2012 04:00:00 +0100 | Der Urologe. Ausg. A
Authors: Schmitz-Dräger BJ, Lümmen G, Bismarck E, Fischer C, Abstract During the last decade consideration of the role of vitamins and minerals in primary prevention of genitourinary tumors has changed dramatically. Despite all efforts the efficacy of a specific compound has not yet been proven and as a consequence recommendations for the use of vitamins or other supplements for tumor prevention should no longer be given. In contrast life style modification might be helpful as recent investigations suggested that smoking not only promotes the development of bladder cancer but is also involved in prostate and renal cell carcinogenesis. In addition there is some evidence that moderate food consumption, reduction of dairy product consumption and an Asian or Mediterranean diet can p...

FDA: Label changes for finasteride expand list of adverse events
Tue, 24 Apr 2012 06:11:40 +0100 | Modern Medicine
The FDA has announced changes to the professional labels for finasteride, 5 mg (Proscar), and finasteride, 1 mg (Propecia), and to expand the list of sexual adverse events reported to the FDA, as some of these events have been reported to continue after the drug is no longer being used. (Source: Modern Medicine)

Case reports suggest a broader range of sexual adverse events in patients receiving finasteride [Propecia, Proscar] than previously reported
Tue, 24 Apr 2012 05:18:13 +0100 | Reactions
(Source: Reactions)

PROSCAR (Finasteride) Tablet, Film Coated [Merck Sharp Dohme Corp.]
Tue, 24 Apr 2012 05:00:00 +0100 | DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST)
Updated Date: Apr 24, 2012 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))

PROPECIA (Finasteride) Tablet, Film Coated [Merck Sharp Dohme Corp.]
Mon, 23 Apr 2012 05:00:00 +0100 | DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST)
Updated Date: Apr 23, 2012 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))

FDA: Label changes for finasteride expand list of adverse events
Mon, 23 Apr 2012 04:00:00 +0100 | UrologyTimes - BPH
The FDA has announced changes to the professional labels for finasteride, 5 mg (Proscar), and finasteride, 1 mg (Propecia), and to expand the list of sexual adverse events reported to the FDA, as some of these events have been reported to continue after the drug is no longer being used. (Source: UrologyTimes - BPH)

Rottenstein Law Group Relieved by FDA’s Decision to Heighten...
Thu, 19 Apr 2012 17:15:12 +0100 | PRWeb: Medical Pharmaceuticals
The Rottenstein Law Group, which represents clients with claims stemming from adverse side effects caused by Propecia and Proscar, is heartened by the FDA’s April 12, 2012, expansion of Propecia’s and...(PRWeb April 19, 2012)Read the full story at http://www.prweb.com/releases/2012/4/prweb9419198.htm (Source: PRWeb: Medical Pharmaceuticals)


ABOUT TRUST ONLINE